Brief: Trevi Therapeutics Announces Fourth Quarter And Year End 2022 Financial Results And Provides Business Update
16/03/2023 22:50
March 16 (Reuters) - Trevi Therapeutics Inc TRVI.O :
* TREVI THERAPEUTICS ANNOUNCES FOURTH QUARTER AND YEAR END
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* ENDED 2022 WITH CASH, CASH EQUIVALENTS, AND MARKETABLE
SECURITIES OF $120.5 MILLION
* QTRLY BASIC AND DILUTED NET LOSS PER COMMON SHARE $ 0.06
* Q4 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn6X4bzsa
Further company coverage: TRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million